U.S. Adult Obesity Rates Show First Decline in Decades
New data indicates a potential turning point in U.S. adult obesity prevalence, with rates dropping from a 2022 peak.

Evidence of a Turning Point
United States adult obesity rates may be reaching a turning point after decades of steady increase. According to data from the Gallup National Health and Well-Being Index, the U.S. adult obesity rate peaked at a record high of 39.9% in 2022 before gradually declining to 37.0% by 2025. This decrease represents an estimated 7.6 million fewer obese adults compared to three years prior.
Benjamin Rader, an epidemiologist at Harvard Medical School and Boston Children's Hospital, stated that there are "signs that there's going to be a turning point". Rader and his colleagues published a study in 2024 based on data from more than 16 million adults, which suggested a decline in obesity prevalence began in 2023.
Analysis of BMI Trends
A study reviewing the body mass index (BMIs) of 16.7 million U.S. adults over a 10-year period found that the average BMI rose annually to 30.24—a level classified as obese—until it plateaued in 2022. Following this plateau, the average BMI dropped marginally.
John Brownstein, a professor at Harvard Medical School and chief innovation officer at Boston Children's Hospital, noted that the bending of this curve "shows a sign of hope for something that was really a threat to American public health for so many years".
Contributing Factors and Limitations
The rapid increase in the use of weight-loss medications, such as Ozempic and Wegovy, is cited as a potential factor in the shifting rates. Additionally, the formal recognition of obesity as a disease in 2013 is noted as a factor that has helped lower the percentage of obese individuals.
However, some medical professionals urge caution when interpreting these statistics. Dr. Irani noted that variability in statistics often depends on the specific population sampled and emphasized the importance of seeing how these numbers evolve in the long run. Dr. Irani also highlighted the scale of the ongoing challenge, noting that while obesity rates are approximately 40%, the combined category of overweight and obese adults now reaches 70%.
Divergent Trends in Children and Teens
While adult trends show signs of slowing or declining, the situation for younger populations differs. A CDC report found that U.S. child and teen obesity rates have reached record highs.
Regarding the 2-to-5-year-old age group, obesity rates declined from 12.1% in 2009-2010 to 9.4% in 2013-2014. However, these rates subsequently increased and currently stand at 14.9%. Ludwig, cited in the report, described the previous dip as a "statistical aberration" and a "mirage" rather than a true shift in the overall upward trend for children.
Concurrent Health Metrics
Despite the decline in obesity rates, other health metrics continue to rise. According to the Gallup National Health and Well-Being Index, diagnoses of diabetes—a lifetime disease that can be managed but not cured—have reached an all-time high of 13.8%.
Sources (8)Open
- 1.Deutsche Welle — Is the US seeing a turning point in obesity rates?
- 2.Dw — Is the US seeing a turning point in obesity rates?
- 3.Dhakatribune — Is the US seeing a turning point in obesity rates?
- 4.Abcnews — US child, teen obesity rates reach record high while adult trends appear to slow, CDC report finds
- 5.Gallup — Obesity Rate Declining in U.S.
- 6.Abcnews — US obesity rates drop for 1st time in a decade, with possible help from weight loss medications - ABC News
- 7.Denver7 — What is influencing a change in obesity rates in the United States
- 8.Inquirer — Japan vows support for US-sanctioned ICC head amid criticism
Topics
How NewsNews AI made this storyOpen
NewsNews AI researched this story across 8 sources, drafted it, and ran the result through an independent editorial pass. It cleared editorial review on first pass.
- 8 sources cited · linked in full at the bottom of the article
- Image license verified · unsplash
- Independent editorial pass · approved
From the editor
19 claims in this story were checked against the source cited for each, and quoted material was matched to the reporting it came from. The story draws on 8 sources, 6 of which carry claims in the finished piece. Nothing required changing.
Feedback
We want to hear from you, especially when something is wrong. No signup, no email required.
Keep reading

Experimental Pill Nearly Doubles Survival Time for Advanced Pancreatic Cancer
Clinical trial data shows daraxonrasib extends median survival to 13.2 months compared to 6.7 months for chemotherapy in patients with metastatic pancreatic cancer.

Researchers Maintain Human Brain Organoids for Over Five Years
Scientists have successfully maintained lab-grown brain tissue for more than five years, mirroring aspects of human brain development over an extended period.

AI-Powered Blood Tests Show Potential for Early Lung Cancer Detection
Researchers are utilizing artificial intelligence to identify DNA fragment patterns and protein markers in blood to detect lung cancer at earlier, more treatable stages.